Th1 type CD4+ T cells may be a potent effector against poorly immunogenic syngeneic tumors

This publication has 20 references indexed in Scilit:

• Cytostasis of different tumours by a murine PPD-reactive CD4+ T lymphocyte clone is mediated by interferon-gamma and tumour necrosis factor alone or synergistically
  Clinical and Experimental Immunology, 2008
• Diversity of Cytokine Synthesis and Function of Mouse CD4⁺ T Cells
  Immunological Reviews, 1991
• Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells
  Published by Elsevier ,1991
• Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
  New England Journal of Medicine, 1988
• Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor.
  The Journal of Experimental Medicine, 1988
• Phenotypically and functionally distinct T-cell subsets in anti-tumor responses
  Immunology Today, 1987
• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986
• The role of cytostasis in antitumor immunity: Comparison between syngeneic and allogeneic systems
  Cellular Immunology, 1985
• Mechanisms of “cytostasis” of tumours in vitro by syngeneic lymphoid cells of tumour bearers
  Cellular Immunology, 1979
• A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin
  British Journal of Cancer, 1976